Skip to Content

BMS 1611 (Baraclude 0.5 mg)

Generic Name: entecavir

Pill imprint BMS 1611 has been identified as Baraclude 0.5 mg.

Baraclude is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Baraclude 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Baraclude 0.5 mg BMS 1611
Baraclude 0.5 mg BMS 1611
Discount Card Promo
Baraclude
Generic Name:
entecavir
Imprint:
BMS 1611
Strength:
0.5 mg
Color:
White
Shape:
Three-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-1611
Inactive Ingredients:
lactose monohydrate
microcrystalline cellulose
crospovidone
povidone
magnesium stearate
titanium dioxide
hypromelloses
polyethylene glycol 400
polysorbate 80
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
49884-0104 Par Pharmaceutical, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide